Textbook of Coronary Thrombosis and Thrombolysis
Teleologically, the hemostatic mechanism is among The of Coronary Thrombosis and the most fundamental yet complex physiologic pro- in essence, represents a heartfelt gift of cesses in humans. Early scientists and physicians were knowledge from a dedicated group of scientists and fascinated by the bl...
| Συγγραφή απο Οργανισμό/Αρχή: | |
|---|---|
| Άλλοι συγγραφείς: | |
| Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
| Γλώσσα: | English |
| Έκδοση: |
Boston, MA :
Springer US,
1997.
|
| Σειρά: | Developments in Cardiovascular Medicine,
193 |
| Θέματα: | |
| Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Scientific Principles
- Biochemistry of Intra Vascular Clotting: Focus on the Prothrombinase Complex
- Plasma Coagulation Factors
- Platelets: Structure, Function, and Their Fundamental Contribution to Hemostasis and Pathologic Thrombosis
- Molecular Regulation of Fibrinolysis
- Plasminogen Activator Inhibitor-1
- Biological Effects of Targeted Gene Inactivation and Gene Transfer of the Coagulation and Fibrinolytic Systems in Mice
- Molecular Approaches to The Design of New Thrombolytic Agents
- Endothelial Cell Biology
- Physiology of Vascular Homeostasis
- Coronary Vascular Pharmacology
- Experimental Models of Coronary Arterial Resistance and Blood Flow
- Pathogenesis of the Acute Coronary Syndromes: Hypotheses Generated from Clinical Experience
- Plaque Disruption and Thrombosis: Models to Evaluate Acute Cardiovascular Events
- Developing Antithrombotic and Thrombolytic Agents: The Role of Experimental Models
- Clinical Application of Scientific Principles
- Streptokinase: Biochemistry and Phamacokinetics
- Anistreplase (Anisoylated Plasminogen Streptokinase Activator Complex, Apsac) in Coronary Thrombolysis
- Biochemistry, Pharmacokinetics, and Dynamics of Single- and Two- Chain Urokinase
- Staphylokinase: Biochemistry And Pharmacodynamics
- Novel Tissue Plasminogen Activators: Reteplase (R-PA)
- Chemistry, Pharmacokinetics, and Pharmacodynamics of T-PA, TNK and DSPA Alpha 1
- National Goals and Perspectives for Improving Patient Care: the National Heart Attack Alert Program
- Delays in Treatment of Acute Myocardial Infarction in the Emergency Department: Reducing Door to Drug Time
- Factors Associated With Prehospital Delay And Overview Of Community Trials To Reduce The Duration Of Prehospital Delay In Patients With Symptoms Of Acute Coronary Disease
- Emergency Medical Services
- Prehospital Approaches to Treating Sudden Cardiac Death and Acute Myocardial Infarction
- Identification of Acute Cardiac Ischemia in the Emergency Department
- The Scientific Basis and Rationale For Early Thrombolytic Therapy
- Patient Selection for Thrombolytic Therapy for Evolving Myocardial Infarction
- Aspirin, Heparin, and New Antithrombotic Drugs as Adjuncts to Thrombolytic Therapy for Acute Myocaradial Infarction
- New Antiplatelet Strategies in the Adjunctive Treatment of Acute Myocardial Infarction
- Experimental Evidence for Enhancement of Thrombolysis by Conventional Thrombolytic Drugs
- Early Diagnosis of Myocardial Infarction with MB-CK Subforms
- Troponins as early markers of acute myocardial infarction
- Markers of Thrombosis and Fibrinolysis
- Markers of Coronary Recanalization after Thrombolysis
- Anticoagulant Monitoring
- Anticoagulation Monitoring for Percutaneous Transluminal Coronary Angioplasty
- Monitoring Chronic Oral Anticoagulant Therapy
- Hemorrhagic Complications
- Gene therapy for the vulnerable plaque
- Gene Therapy: Vector Design and Current Challenges
- New Dimensions
- Role of Inflammation Following Myocardial Ischemia and Reperfusion
- Estrogen and Cardiovascular Disease
- Evolution of Thrombocardiology
- Drugs in Development
- Clinical Trials of Novel Antithrombotics: Basic Concepts of Study Design and Methodology
- A Glossary of Terms in Thrombocardiology.
